167 related articles for article (PubMed ID: 20148423)
21. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology.
Suvas S; Kim B; Sarangi PP; Tone M; Waldmann H; Rouse BT
J Virol; 2005 Sep; 79(18):11935-42. PubMed ID: 16140769
[TBL] [Abstract][Full Text] [Related]
22. A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model.
D'Addio F; Yuan X; Habicht A; Williams J; Ruzek M; Iacomini J; Turka LA; Sayegh MH; Najafian N; Ansari MJ
Transplantation; 2010 Aug; 90(3):260-9. PubMed ID: 20712076
[TBL] [Abstract][Full Text] [Related]
23. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
[TBL] [Abstract][Full Text] [Related]
24. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
25. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
[TBL] [Abstract][Full Text] [Related]
27. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
[TBL] [Abstract][Full Text] [Related]
28. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival.
Curry AJ; Chikwe J; Smith XG; Cai M; Schwarz H; Bradley JA; Bolton EM
Transplantation; 2004 Sep; 78(6):807-14. PubMed ID: 15385798
[TBL] [Abstract][Full Text] [Related]
29. Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection.
Dittmer U; Werner T; Kraft AR
Viral Immunol; 2008 Dec; 21(4):459-67. PubMed ID: 19115935
[TBL] [Abstract][Full Text] [Related]
30. GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts.
Hori J; Taniguchi H; Wang M; Oshima M; Azuma M
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6556-65. PubMed ID: 20702832
[TBL] [Abstract][Full Text] [Related]
31. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
Nocentini G; Ronchetti S; Petrillo MG; Riccardi C
Br J Pharmacol; 2012 Apr; 165(7):2089-99. PubMed ID: 22029729
[TBL] [Abstract][Full Text] [Related]
33. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
Prigozhina TB; Gurevitch O; Elkin G; Morecki S; Yakovlev E; Slavin S
Exp Hematol; 2003 Jan; 31(1):81-8. PubMed ID: 12543110
[TBL] [Abstract][Full Text] [Related]
35. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
[TBL] [Abstract][Full Text] [Related]
36. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations.
Ronchetti S; Zollo O; Bruscoli S; Agostini M; Bianchini R; Nocentini G; Ayroldi E; Riccardi C
Eur J Immunol; 2004 Mar; 34(3):613-622. PubMed ID: 14991590
[TBL] [Abstract][Full Text] [Related]
37. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
Ferrari-Lacraz S; Zheng XX; Kim YS; Li Y; Maslinski W; Li XC; Strom TB
J Immunol; 2001 Sep; 167(6):3478-85. PubMed ID: 11544341
[TBL] [Abstract][Full Text] [Related]
38. Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.
You S; Poulton L; Cobbold S; Liu CP; Rosenzweig M; Ringler D; Lee WH; Segovia B; Bach JF; Waldmann H; Chatenoud L
PLoS One; 2009 Nov; 4(11):e7848. PubMed ID: 19936238
[TBL] [Abstract][Full Text] [Related]
39. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.
Igarashi H; Cao Y; Iwai H; Piao J; Kamimura Y; Hashiguchi M; Amagasa T; Azuma M
Biochem Biophys Res Commun; 2008 May; 369(4):1134-8. PubMed ID: 18346459
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.
Quezada SA; Bennett K; Blazar BR; Rudensky AY; Sakaguchi S; Noelle RJ
J Immunol; 2005 Jul; 175(2):771-9. PubMed ID: 16002673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
